Trials / Completed

CompletedNCT02159651

A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia

Specified Drug Use-results Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis

Status: Completed
Phase: —
Study type: Observational
Enrollment: 179 (actual)

Sponsor: Astellas Pharma Inc · Industry
Sex: All
Age: —
Healthy volunteers: Not accepted

Summary

This study is to evaluate the safety and the efficacy of Prograf in patients with interstitial pneumonia associated with polymyositis / dermatomyositis in acute clinical setting.

Conditions

Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis

Interventions

Type	Name	Description
DRUG	tacrolimus	oral

Timeline

Start date: 2014-04-01
Primary completion: 2019-12-23
Completion: 2019-12-23
First posted: 2014-06-10
Last updated: 2024-10-22

Locations

8 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT02159651. Inclusion in this directory is not an endorsement.